Valcon Medical A/S: Financial statements 2022
CVR: 40086714
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Valcon Medical A/S (CVR 40086714) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -15,349,994 and a net result of DKK -17,079,193 compared with DKK -10,627,248 the year before. Equity in the 2022 report amounted to DKK 56,675,233. The solvency ratio was 84.3%. The company had 20 employees in the financial year.
- Gross Profit
- DKK -15,349,994
- Profit/Loss
- DKK -17,079,193
- Equity
- DKK 56,675,233
- Total Assets
- DKK 67,254,637
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -15.3M | -17.1M | 56.7M | 20 |
| 2021 | - | -6.2M | -10.6M | 49.4M | 12 |
| 2020 | - | -1.1M | -3.5M | 640K | 8 |
| 2019 | - | -3M | -4.3M | 9.7M | 5 |
Official annual report
Keep an eye on Valcon Medical A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Valcon Medical A/S has published its annual report for 2021. Gross profit came to DKK -6,235,445, and the net result was DKK -10,627,248.
About Valcon Medical A/S
Valcon Medical A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2018. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The company was previously named Aureum A/S. The management consists of Peter Emil Guldmann Sigetty. The board consists of Alex Sung Kwon (chair), Douglas Fischer, Ruchir Ashok Kadakia and William Muecke. The company is owned by BTS DK ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 2,139,839 and a net result of DKK -11,198,587 compared with EUR -41,728,331 the year before. Equity in the 2025 report amounted to DKK 11,420,803.
